疏肝健脾化瘀法治疗慢性乙型病毒性肝炎的临床观察  

Observation on treating chronic hepatitis B by the Shugan Jianpi Huayu therapy

作　　者：李洪波[1] 刘义安[1] 

机构地区：[1]江苏省苏州市第五人民医院,江苏苏州215002

出　　处：《中医临床研究》2017年第14期59-61,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:对慢性乙型病毒性肝炎患者行疏肝健脾化瘀法的有效性进行观察。方法:从2012年1月—2016年12月因出现慢性乙型病毒性肝炎而进入本院治疗的患者中随机筛选60例进行研究,予以对照分组,对照组30例均以还原型谷胱甘肽、复方甘草酸苷、多烯卵磷脂保肝降酶,而治疗组30例则联合疏肝健脾化瘀法进行治疗,并对两组疗效客观对照。结果:对照组总效率为63.33%(19/30),治疗组为93.33%(28/30),P<0.05;此外,治疗后,两组患者的谷丙氨酸氨基转移酶指数、总胆红素以及直接胆红素等对照差异显著(P<0.05);同时两组中医证候分数相对照,同样有差异(P<0.05)。结论:慢性乙型病毒性肝炎症状的患者通过疏肝健脾化瘀法进行治疗,除了能提升疗效、改善中医证候分数外,还能进一步改善谷丙氨酸氨基转移酶指数、总胆红素以及直接胆红素等肝功能指标,所以可推广。Objective:To observe the effects of the Shugan Jianpi Huayu therapy on chronic hepatitis B.Methods:60patients were randomly selected and divided into two group,30cases in each.The control group was treated with GSH,compoundglycyrrhizin,polyene lecithin to protect the liver and reduce the enzyme;and the treatment group was treated by the Shugan JianpiHuayu therapy.Results:The efficiency was63.33%(19/30)in the control group and93.33%(28/30)in the treatment group(P<0.05).In addition,the differeces of alanine aminotransferase index,total bilirubin and direct bilirubin and TCM syndrome scores betweengroups were significant(P<0.05).Conclusion:The Shugan Jianpi Huayu therapy on chronic hepatitis B can improve effects,the TCMsyndrome score and liver function indicators such as the alanine aminotransferase index,total bilirubin and direct bilirubin,is worthyof promotion.

关 键 词：还原型谷胱甘肽 慢性乙型病毒性肝炎 肝功能 疏肝健脾化瘀法 中医证候 

分 类 号：R512.6[医药卫生—内科学]